{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:15:59Z","timestamp":1792649759991,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007299","name":"Harvard Catalyst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007299","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006691","name":"Harvard Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007229","name":"Harvard University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 TR001102"],"award-info":[{"award-number":["UL1 TR001102"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtcvsonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jtcvs.2025.02.012","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:14:46Z","timestamp":1739992486000},"page":"379-388.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Incidental use of angiotensin system inhibitors during neoadjuvant therapy for esophageal adenocarcinoma: An analysis of survival"],"prefix":"10.1016","volume":"170","author":[{"given":"Abraham","family":"Geller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Abston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Muniappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Costantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hexiao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6049-1276","authenticated-orcid":false,"given":"Michael","family":"Lanuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2025.02.012_bib1","series-title":"SEER Cancer Stat facts: Esophageal Cancer","year":"2020"},{"issue":"13","key":"10.1016\/j.jtcvs.2025.02.012_bib2","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa2032125","article-title":"Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer","volume":"384","author":"Kelly","year":"2021","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jtcvs.2025.02.012_bib3","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nrc2945","article-title":"The renin-angiotensin system and cancer: old dog, new tricks","volume":"10","author":"George","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"410","key":"10.1016\/j.jtcvs.2025.02.012_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan5616","article-title":"Targeting the renin-angiotensin system to improve cancer treatment: implications for immunotherapy","volume":"9","author":"Pinter","year":"2017","journal-title":"Sci Transl Med"},{"issue":"25","key":"10.1016\/j.jtcvs.2025.02.012_bib5","doi-asserted-by":"crossref","first-page":"10284","DOI":"10.1073\/pnas.0900351106","article-title":"AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist","volume":"106","author":"Rhodes","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.jtcvs.2025.02.012_bib6","first-page":"1073","article-title":"The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor","volume":"7","author":"Yoshiji","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtcvs.2025.02.012_bib7","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1186\/s12885-015-1095-2","article-title":"Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma","volume":"15","author":"He","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jtcvs.2025.02.012_bib8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.xjon.2024.01.014","article-title":"An angiotensin system inhibitor (losartan) potentiates antitumor efficacy of cisplatin in a murine model of non\u2013small cell lung cancer","volume":"18","author":"Tang","year":"2024","journal-title":"JTCVS Open"},{"issue":"10","key":"10.1016\/j.jtcvs.2025.02.012_bib9","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.cgh.2007.08.005","article-title":"Angiotensin-converting enzyme inhibitors and risk of esophageal and gastric cancer: a nested case-control study","volume":"5","author":"Sjoberg","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jtcvs.2025.02.012_bib10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1186\/s12885-022-09513-4","article-title":"Prognostic impact of angiotensin-converting enzyme inhibitors and angiotensin receptors blockers in esophageal or gastric cancer patients with hypertension - a real-world study","volume":"22","author":"Li","year":"2022","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.jtcvs.2025.02.012_bib11","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/1470320314535275","article-title":"Prognostic impact of renin-angiotensin system blockade in esophageal squamous cell carcinoma","volume":"16","author":"Chen","year":"2015","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"22","key":"10.1016\/j.jtcvs.2025.02.012_bib12","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.jtcvs.2025.02.012_bib13","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jtcvs.2025.02.012_bib14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jtcvs.2025.02.012_bib15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.00036.2005","article-title":"Physiology of local renin-angiotensin systems","volume":"86","author":"Paul","year":"2006","journal-title":"Physiol Rev"},{"issue":"5","key":"10.1016\/j.jtcvs.2025.02.012_bib16","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jtcvs.2025.02.012_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1172\/JCI16645","article-title":"Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth","volume":"112","author":"Egami","year":"2003","journal-title":"J Clin Investig"},{"issue":"2","key":"10.1016\/j.jtcvs.2025.02.012_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/carcin\/bgh324","article-title":"Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth","volume":"26","author":"Fujita","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jtcvs.2025.02.012_bib19","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1038\/ncomms3516","article-title":"Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels","volume":"4","author":"Chauhan","year":"2013","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jtcvs.2025.02.012_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40425-018-0316-z","article-title":"Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations","volume":"6","author":"Gong","year":"2018","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jtcvs.2025.02.012_bib21","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1200\/EDBK_175231","article-title":"Immunotherapy for esophageal and gastric cancer","volume":"37","author":"Kelly","year":"2017","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"5","key":"10.1016\/j.jtcvs.2025.02.012_bib22","first-page":"561","article-title":"Immunotherapy for advanced gastric and esophageal cancer: preclinical rationale and ongoing clinical investigations","volume":"6","author":"Raufi","year":"2015","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"10.1016\/j.jtcvs.2025.02.012_bib33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/cas.13423","article-title":"Involvement of local renin-angiotensin system in immunosuppression of tumor microenvironment","volume":"109","author":"Nakamura","year":"2018","journal-title":"Cancer Sci"},{"issue":"9123","key":"10.1016\/j.jtcvs.2025.02.012_bib23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0140-6736(98)03228-0","article-title":"Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?","volume":"352","author":"Lever","year":"1998","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jtcvs.2025.02.012_bib24","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/1097-0142(20011101)92:9<2462::AID-CNCR1596>3.0.CO;2-L","article-title":"Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark","volume":"92","author":"Friis","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.jtcvs.2025.02.012_bib25","article-title":"Impact of angiotensin I-converting enzyme inhibitors and angiotensin II type-1 receptor blockers on survival of patients with NSCLC","volume":"6","author":"Miao","year":"2016","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.jtcvs.2025.02.012_bib26","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00432-009-0587-3","article-title":"Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy","volume":"135","author":"Wilop","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"10.1016\/j.jtcvs.2025.02.012_bib27","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.clgc.2016.03.009","article-title":"The incidence and risk of biochemical recurrence following radical radiotherapy for prostate cancer in men on angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs)","volume":"14","author":"Alashkham","year":"2016","journal-title":"Clin Genitourin Cancer"},{"issue":"2","key":"10.1016\/j.jtcvs.2025.02.012_bib28","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/MPA.0b013e31825de678","article-title":"Clinical outcomes of chemotherapy for diabetic and nondiabetic patients with pancreatic cancer: better prognosis with statin use in diabetic patients","volume":"42","author":"Nakai","year":"2013","journal-title":"Pancreas"},{"issue":"19","key":"10.1016\/j.jtcvs.2025.02.012_bib29","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1158\/1078-0432.CCR-17-0256","article-title":"Use of angiotensin system inhibitors is associated with immune activation and longer survival in nonmetastatic pancreatic ductal adenocarcinoma","volume":"23","author":"Liu","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.jtcvs.2025.02.012_bib30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1593\/tlo.13346","article-title":"Exposure to ACEI\/ARB and beta-blockers is associated with improved survival and decreased tumor progression and hospitalizations in patients with advanced colon cancer","volume":"6","author":"Engineer","year":"2013","journal-title":"Transl Oncol"},{"issue":"1","key":"10.1016\/j.jtcvs.2025.02.012_bib31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/00365590802468875","article-title":"Captopril may reduce biochemical (prostate-specific antigen) failure following radical prostatectomy for clinically localized prostate cancer","volume":"43","author":"Ronquist","year":"2009","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.jtcvs.2025.02.012_bib32","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.8188","article-title":"Retrospective clinical study of renin-angiotensin system blockers in lung cancer patients with hypertension","volume":"7","author":"Wei","year":"2019","journal-title":"PeerJ"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522325001217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522325001217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:03:10Z","timestamp":1783026190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522325001217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0022522325001217"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2025.02.012","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidental use of angiotensin system inhibitors during neoadjuvant therapy for esophageal adenocarcinoma: An analysis of survival","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2025.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by The American Association for Thoracic Surgery","name":"copyright","label":"Copyright"}]}}